These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 17152015)

  • 21. Safety and Immunogenicity of Newborn MVA85A Vaccination and Selective, Delayed Bacille Calmette-Guerin for Infants of Human Immunodeficiency Virus-Infected Mothers: A Phase 2 Randomized, Controlled Trial.
    Nemes E; Hesseling AC; Tameris M; Mauff K; Downing K; Mulenga H; Rose P; van der Zalm M; Mbaba S; Van As D; Hanekom WA; Walzl G; Scriba TJ; McShane H; Hatherill M;
    Clin Infect Dis; 2018 Feb; 66(4):554-563. PubMed ID: 29028973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenicity and Protective Efficacy of the DAR-901 Booster Vaccine in a Murine Model of Tuberculosis.
    Lahey T; Laddy D; Hill K; Schaeffer J; Hogg A; Keeble J; Dagg B; Ho MM; Arbeit RD; von Reyn CF
    PLoS One; 2016; 11(12):e0168521. PubMed ID: 27997597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy.
    Lu M; Xia ZY; Bao L
    Cell Immunol; 2013; 285(1-2):111-7. PubMed ID: 24177251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD4+ T cell cytokine responses to the DAR-901 booster vaccine in BCG-primed adults: A randomized, placebo-controlled trial.
    Masonou T; Hokey DA; Lahey T; Halliday A; Berrocal-Almanza LC; Wieland-Alter WF; Arbeit RD; Lalvani A; von Reyn CF
    PLoS One; 2019; 14(5):e0217091. PubMed ID: 31120957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
    Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
    Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunization of HIV-infected adults with a three-dose series of inactivated Mycobacterium vaccae.
    Marsh BJ; Fordham von Reyn C; Arbeit RD; Morin P
    Am J Med Sci; 1997 Jun; 313(6):377-83. PubMed ID: 9186154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of maternal infection with Mycobacterium tuberculosis on the infant response to bacille Calmette-Guérin immunization.
    Mawa PA; Nkurunungi G; Egesa M; Webb EL; Smith SG; Kizindo R; Akello M; Lule SA; Muwanga M; Dockrell HM; Cose S; Elliott AM
    Philos Trans R Soc Lond B Biol Sci; 2015 Jun; 370(1671):. PubMed ID: 25964450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intradermal and oral immunization with recombinant Mycobacterium bovis BCG expressing the simian immunodeficiency virus Gag protein induces long-lasting, antigen-specific immune responses in guinea pigs.
    Kawahara M; Matsuo K; Honda M
    Clin Immunol; 2006 Apr; 119(1):67-78. PubMed ID: 16386958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double-blind, placebo-controlled study of Mycobacterium-specific human immune responses induced by intradermal bacille Calmette-Guérin vaccination.
    Hoft DF; Kemp EB; Marinaro M; Cruz O; Kiyono H; McGhee JR; Belisle JT; Milligan TW; Miller JP; Belshe RB
    J Lab Clin Med; 1999 Sep; 134(3):244-52. PubMed ID: 10482309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of bacille Calmette-Guerin vaccine strain on the immune response against tuberculosis: a randomized trial.
    Ritz N; Dutta B; Donath S; Casalaz D; Connell TG; Tebruegge M; Robins-Browne R; Hanekom WA; Britton WJ; Curtis N
    Am J Respir Crit Care Med; 2012 Jan; 185(2):213-22. PubMed ID: 22071384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies.
    Black GF; Weir RE; Floyd S; Bliss L; Warndorff DK; Crampin AC; Ngwira B; Sichali L; Nazareth B; Blackwell JM; Branson K; Chaguluka SD; Donovan L; Jarman E; King E; Fine PE; Dockrell HM
    Lancet; 2002 Apr; 359(9315):1393-401. PubMed ID: 11978337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The safety and immunogenicity of an adenovirus type 35-vectored TB vaccine in HIV-infected, BCG-vaccinated adults with CD4(+) T cell counts >350 cells/mm(3).
    Churchyard GJ; Snowden MA; Hokey D; Dheenadhayalan V; McClain JB; Douoguih M; Pau MG; Sadoff J; Landry B
    Vaccine; 2015 Apr; 33(15):1890-6. PubMed ID: 25698492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polyantigenic interferon-γ responses are associated with protection from TB among HIV-infected adults with childhood BCG immunization.
    Lahey T; Mitchell BK; Arbeit RD; Sheth S; Matee M; Horsburgh CR; MacKenzie T; Mtei L; Bakari M; Vuola JM; Pallangyo K; von Reyn CF
    PLoS One; 2011; 6(7):e22074. PubMed ID: 21799772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of HIV exposure and maternal Mycobacterium tuberculosis infection on infant immune responses to bacille Calmette-Guérin vaccination.
    Jones CE; Hesseling AC; Tena-Coki NG; Scriba TJ; Chegou NN; Kidd M; Wilkinson RJ; Kampmann B
    AIDS; 2015 Jan; 29(2):155-65. PubMed ID: 25535752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis of latent tuberculosis infection in bacille Calmette-Guérin vaccinated subjects in China by interferon-gamma ELISpot assay.
    Zhang M; Wang H; Liao M; Chen X; Graner M; Zhu X; Zhang J; Yang Q; Lu H; Zhou B; Chen X
    Int J Tuberc Lung Dis; 2010 Dec; 14(12):1556-63. PubMed ID: 21144240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tuberculin skin test conversion in hospital employees vaccinated with bacille Calmette-Guérin: recent Mycobacterium tuberculosis infection or booster effect?
    Horowitz HW; Luciano BB; Kadel JR; Wormser GP
    Am J Infect Control; 1995 Jun; 23(3):181-7. PubMed ID: 7677263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of immunogenic effect of the BCG priming and Ag85A- GM-CSF boosting in Balb/c mice model.
    Dou J; Tang Q; Yu F; Yang H; Zhao F; Xu W; Wang J; Hu W; Hu K; Liou C; Feng He X; Wang Y
    Immunobiology; 2010; 215(2):133-42. PubMed ID: 19450898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune response in healthy volunteers vaccinated with killed leishmanial promastigotes plus BCG. I: Skin-test reactivity, T-cell proliferation and interferon-gamma production.
    Castés M; Blackwell J; Trujillo D; Formica S; Cabrera M; Zorrilla G; Rodas A; Castellanos PL; Convit J
    Vaccine; 1994 Aug; 12(11):1041-51. PubMed ID: 7975845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of a booster tuberculosis vaccine containing mycobacterial DNA-binding protein 1 and CpG oligodeoxynucleotide G9.1 using a Guinea pig model that elicits immunity to Bacillus Calmette-Guérin.
    Maeyama JI; Iho S; Suzuki F; Hayashi D; Yamamoto T; Yamazaki T; Goto Y; Ozeki Y; Matsumoto S; Yamamoto S
    Tuberculosis (Edinb); 2021 May; 128():102067. PubMed ID: 33752142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.